Sharing certain assumptions but differing in theory and practice, both Columbia School linguistics (CS) and Cognitive Grammar (CG) have increasingly supported their analyses with quantitative evidence. Citation of individual sentences, in isolation or in context, has been supplemented with counts of linguistic forms in texts, informant questionnaires, and perception tests. The present volume, continuing a dialogue between CS and CG, offers six such qualitative-quantitative studies, one on Afrikaans and five on Dutch. Topics include (a) demonstratives, (b) pragmatic particles and imperatives, (c) a puzzling “dismissive” idiom, (d) progressive aspect, and (e) indirect objects. While CS is better suited for analyzing relatively closed systems (e.g. tense, pronouns), CG provides more insight into the vagaries of the amorphous lexicon. The author also offers personal remarks on “linguistics as a path” and discusses how in one case a wrong prediction reflects his dual role as both linguist and student of Dutch as a foreign language.
Conn’s Current Therapy 2011 is an easy-to-use, in-depth guide to the latest advances in therapeutics for common complaints and diagnoses. Drs. Edward T. Bope, Rick D. Kellerman, and Robert E. Rakel present the expertise and knowledge of hundreds of skilled international leaders on the full range of evidence-based management options. With coverage of recent developments in travel medicine, sleep apnea, and immunization practices, as well as standardized diagnostic points and clinical recommendation tables, you’ll have access to the information you need. Deliver effective treatment after making correct diagnoses through discussions of important diagnostic criteria in each chapter. Get the best, most practical and accurate advice from acknowledged expert contributors. Apply best practices from around the world from coverage of management methods used by international experts. Stay current with recent developments in travel medicine, sleep apnea, immunization practices, and much more. Know the full range of treatment options through coverage of the latest information on recently-approved and soon-to-be-approved drugs. Tap into the guidance of experts for practical and accurate advice on diagnosis and management. Find the answers you need more easily with standardized Current Diagnostic Points and Current Therapy clinical recommendation tables. Accurately code for reimbursement using an up-to-date ICD-9 list of common diseases and codes.
Conn's Current Therapy 2010 provides concise and easy-to-use guidance on the latest advances in therapeutics for common complaints and diagnoses. Edward T. Bope, MD; Robert E. Rakel, MD; and Rick D. Kellerman offer their expertise and the knowledge of hundreds of skilled international leaders on the full range of evidence-based management options. Tap into recent developments and thorough updates on myelodysplastic syndromes, psychocutaneous medicine, recently-approved and soon-to-be-approved drugs, and much more to stay on top of current treatment practices. With the full text online at expertconsult.com, you'll have the information you need right at your fingertips for easy access! Provides access to the full contents of the text online at expertconsult.com. Discusses recent developments and thorough updates on myelodysplastic syndromes, psychocutaneous medicine, recently-approved and soon-to-be-approved drugs, and much so you can stay on top of current treatment practices. Contains important diagnostic criteria in each chapter because correct diagnoses lead to the delivery of effective treatment. Features acknowledged expert contributors for each chapter so you know that you are getting the best and most practical and accurate advice. Presents management methods used by international experts to provide you with best practices from around the world. Covers most common major presenting symptoms in a section on symptomatic care to assure that your patients can get the best possible treatment while tests are being performed. Incorporates the latest information on recently-approved and soon-to-be-approved drugs so you are aware of all treatment options. Includes the ICD-9 list of common diseases and codes on end papers to enable you and your staff to accurately code for reimbursement.
This guide offers a different approach from the misleading formulae for success offered by much self-help business literature. The authors believe that in today's turbulent competitive environment, it is necessary to embrace uncertainty and set more realistic expectations.
Approximately 29 million Americans are diagnosed with Type 2 diabetes annually. Of that number, only about 36 percent (10.44 million diabetes sufferers) achieve satisfactory medical outcomes and would need additional help—rarely available—to reliably control their glucose levels. Contrary to popular belief, although anti-diabetic medications can lower sugar levels, nevertheless they have a poor performance track record because inflammation in the blood vessels persists. This book details recent scientific findings that cardiovascular, kidney, vision, peripheral nervous system, and other body damage caused by chronic high levels of blood sugar (hyperglycemia) in Type 2 diabetes is actually due to excessive generation of unopposed free radicals and reactive oxygen species (ROS). These, in turn, cause chronic systemic inflammation and dysfunction of the endothelial lining of the arterial blood vessels, jeopardizing the formation of the protective molecule nitric oxide (NO), thus severely impairing the blood supply to every organ and tissue in the body. This book also catalogues the evidence that chronic hyperglycemia causes profound and often irreversible damage—even long before Type 2 diabetes has been diagnosed. In addition, because conventional prescription treatments are, unfortunately, often inadequate, the book details evidence-based complementary means of blood sugar control.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.